Skubisz, K.; Dąbkowski, K.; Samborowska, E.; Starzyńska, T.; Deskur, A.; Ambrozkiewicz, F.; Karczmarski, J.; Radkiewicz, M.; Kusnierz, K.; Kos-Kudła, B.;
et al. Serum Metabolite Biomarkers for Pancreatic Tumors: Neuroendocrine and Pancreatic Ductal Adenocarcinomas—A Preliminary Study. Cancers 2023, 15, 3242.
https://doi.org/10.3390/cancers15123242
AMA Style
Skubisz K, Dąbkowski K, Samborowska E, Starzyńska T, Deskur A, Ambrozkiewicz F, Karczmarski J, Radkiewicz M, Kusnierz K, Kos-Kudła B,
et al. Serum Metabolite Biomarkers for Pancreatic Tumors: Neuroendocrine and Pancreatic Ductal Adenocarcinomas—A Preliminary Study. Cancers. 2023; 15(12):3242.
https://doi.org/10.3390/cancers15123242
Chicago/Turabian Style
Skubisz, Karolina, Krzysztof Dąbkowski, Emilia Samborowska, Teresa Starzyńska, Anna Deskur, Filip Ambrozkiewicz, Jakub Karczmarski, Mariusz Radkiewicz, Katarzyna Kusnierz, Beata Kos-Kudła,
and et al. 2023. "Serum Metabolite Biomarkers for Pancreatic Tumors: Neuroendocrine and Pancreatic Ductal Adenocarcinomas—A Preliminary Study" Cancers 15, no. 12: 3242.
https://doi.org/10.3390/cancers15123242
APA Style
Skubisz, K., Dąbkowski, K., Samborowska, E., Starzyńska, T., Deskur, A., Ambrozkiewicz, F., Karczmarski, J., Radkiewicz, M., Kusnierz, K., Kos-Kudła, B., Sulikowski, T., Cybula, P., & Paziewska, A.
(2023). Serum Metabolite Biomarkers for Pancreatic Tumors: Neuroendocrine and Pancreatic Ductal Adenocarcinomas—A Preliminary Study. Cancers, 15(12), 3242.
https://doi.org/10.3390/cancers15123242
